Showing 20 of 63 recruiting trials for “Clear cell renal carcinoma”
Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma
Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma
RecruitingNCT06195150 ↗
Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer
A Study of Cadonilimab（AK104） Plus Lenvatinib in Previous Immunotherapy Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma
Autologous Dendritic Cell Vaccine in Kidney Cancer
The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial
👨⚕️ Won Sik Ham, Department of Urology and Urological Science Institute, Yonsei University College of Medicine📍 3 sites📅 Started Jul 2023View details ↗
Fruquintinib and SeRplulimab: Opening New Frontiers in Treating Non-clear Cell Renal Cell Carcinoma
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell Carcinoma
Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk Recurrence Factors
👨⚕️ hongqian guo, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School📍 2 sites📅 Started Feb 2023View details ↗
Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
👨⚕️ Stephanie L Goff, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Aug 2022View details ↗
RecruitingNCT05214885 ↗
Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma
👨⚕️ Li Zhang, Dr., The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital📍 1 site📅 Started Feb 2022View details ↗
NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma
👨⚕️ Shankar Siva, A/Prof, Peter MacCallum Cancer Centre, Australia📍 2 sites📅 Started Feb 2022View details ↗
Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell
[18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
A Beta-only IL-2 ImmunoTherapY Study
[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma
👨⚕️ James Brugarolas, MD, PhD, University of Texas Southwestern Medical Center📍 1 site📅 Started Aug 2021View details ↗
RecruitingNCT04053855 ↗
Evaluation of Urinary Exosomes Presence From Clear Cell Renal Cell Carcinoma
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
👨⚕️ Clinical Trials Management, Regeneron Pharmaceuticals📍 21 sites📅 Started Aug 2019View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →